| Year |
Citation |
Score |
| 2023 |
Nes MS, Haugen M, Haugland HK, Gilhus NE, Vedeler CA. Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1. Frontiers in Neurology. 14: 1237140. PMID 37900608 DOI: 10.3389/fneur.2023.1237140 |
0.566 |
|
| 2023 |
Gilhus NE. Myasthenia gravis and congenital myasthenic syndromes. Handbook of Clinical Neurology. 195: 635-652. PMID 37562891 DOI: 10.1016/B978-0-323-98818-6.00010-8 |
0.359 |
|
| 2023 |
Ozyurt Kose S, Nazli E, Tutkavul K, Gilhus NE. Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis. Frontiers in Neurology. 14: 1201451. PMID 37521306 DOI: 10.3389/fneur.2023.1201451 |
0.336 |
|
| 2023 |
Aanestad E, Gilhus NE, Olberg HK, Kural MA, Beniczky S, Brogger J. Spike count and morphology in the classification of epileptiform discharges. Frontiers in Neurology. 14: 1165592. PMID 37288067 DOI: 10.3389/fneur.2023.1165592 |
0.752 |
|
| 2023 |
Gilhus NE. Myasthenia gravis, respiratory function, and respiratory tract disease. Journal of Neurology. 1-12. PMID 37101094 DOI: 10.1007/s00415-023-11733-y |
0.31 |
|
| 2023 |
Gilhus NE. Treatment considerations in myasthenia gravis for the pregnant patient. Expert Review of Neurotherapeutics. 23: 169-177. PMID 36786092 DOI: 10.1080/14737175.2023.2178302 |
0.329 |
|
| 2022 |
Eid K, Torkildsen Ø, Aarseth J, Aalstad M, Bhan A, Celius EG, Cortese M, Daltveit AK, Holmøy T, Myhr KM, Riise T, Schüler S, Torkildsen CF, Wergeland S, Gilhus NE, et al. Association of adverse childhood experiences with the development of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 35379699 DOI: 10.1136/jnnp-2021-328700 |
0.471 |
|
| 2021 |
Schneider-Gold C, Gilhus NE. Advances and challenges in the treatment of myasthenia gravis. Therapeutic Advances in Neurological Disorders. 14: 17562864211065406. PMID 34987614 DOI: 10.1177/17562864211065406 |
0.346 |
|
| 2021 |
Husebye ESN, Riedel B, Bjørke-Monsen AL, Spigset O, Daltveit AK, Gilhus NE, Bjørk MH. Vitamin B status and association with antiseizure medication in pregnant women with epilepsy. Epilepsia. PMID 34590314 DOI: 10.1111/epi.17076 |
0.473 |
|
| 2021 |
Aanestad E, Gilhus NE, Brogger J. A New Score for Sharp Discharges in the EEG Predicts Epilepsy. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. PMID 33935218 DOI: 10.1097/WNP.0000000000000849 |
0.752 |
|
| 2020 |
Hong Y, Liang X, Gilhus NE. AChR antibodies show a complex interaction with human skeletal muscle cells in a transcriptomic study. Scientific Reports. 10: 11230. PMID 32641696 DOI: 10.1038/S41598-020-68185-X |
0.388 |
|
| 2020 |
Gilhus NE. Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child. Frontiers in Neurology. 11: 554. PMID 32595594 DOI: 10.3389/fneur.2020.00554 |
0.303 |
|
| 2020 |
Gilhus NE. Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child Frontiers in Neurology. 11: 554. DOI: 10.3389/Fneur.2020.00554 |
0.419 |
|
| 2019 |
Wie Børsheim A, Engeland A, Gilhus NE. Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort. Seizure. 75: 89-95. PMID 31918165 DOI: 10.1016/J.Seizure.2019.12.015 |
0.321 |
|
| 2019 |
Husebye ESN, Gilhus NE, Spigset O, Daltveit AK, Bjørk MH. Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - The Norwegian Mother and Child Cohort Study. European Journal of Neurology. PMID 31814202 DOI: 10.1111/Ene.14140 |
0.527 |
|
| 2019 |
Aanestad E, Gilhus NE, Brogger J. Interictal epileptiform discharges vary across age groups. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 131: 25-33. PMID 31751836 DOI: 10.1016/J.Clinph.2019.09.017 |
0.755 |
|
| 2019 |
Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nature Reviews. Disease Primers. 5: 30. PMID 31048702 DOI: 10.1038/s41572-019-0079-y |
0.391 |
|
| 2019 |
Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE. Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. PMID 30972499 DOI: 10.1007/S00415-019-09292-2 |
0.643 |
|
| 2018 |
Husebye ESN, Gilhus NE, Riedel B, Spigset O, Daltveit AK, Bjørk MH. Verbal abilities in children of mothers with epilepsy: Association to maternal folate status. Neurology. PMID 30068633 DOI: 10.1212/Wnl.0000000000006073 |
0.53 |
|
| 2018 |
Hong Y, Li HF, Romi F, Skeie GO, Gilhus NE. HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis. Acta Neurologica Scandinavica. PMID 29736936 DOI: 10.1111/Ane.12951 |
0.743 |
|
| 2018 |
Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. Journal of Neurology. PMID 29372387 DOI: 10.1007/S00415-018-8751-9 |
0.675 |
|
| 2017 |
Bjørk M, Riedel B, Spigset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. Jama Neurology. PMID 29279889 DOI: 10.1001/Jamaneurol.2017.3897 |
0.522 |
|
| 2017 |
Romi F, Hong Y, Gilhus NE. Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Current Opinion in Immunology. 49: 9-13. PMID 28780294 DOI: 10.1016/J.Coi.2017.07.006 |
0.767 |
|
| 2017 |
Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, Hao HJ, Gao X, Owe JF, Zhang X, Yue YX, Romi F, Wang Q, Li HF, Gilhus NE, et al. Multiple antibody detection in 'seronegative' myasthenia gravis patients. European Journal of Neurology. PMID 28470860 DOI: 10.1111/Ene.13300 |
0.787 |
|
| 2017 |
Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. PMID 28364296 DOI: 10.1007/S00415-017-8478-Z |
0.747 |
|
| 2016 |
Hong Y, Li HF, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. Journal of Neuroimmunology. 298: 51-7. PMID 27609275 DOI: 10.1016/J.Jneuroim.2016.07.001 |
0.787 |
|
| 2016 |
Reiter SF, Bjørk MH, Daltveit AK, Veiby G, Kolstad E, Engelsen BA, Gilhus NE. Life satisfaction in women with epilepsy during and after pregnancy. Epilepsy & Behavior : E&B. 62: 251-257. PMID 27513352 DOI: 10.1016/J.Yebeh.2016.06.025 |
0.53 |
|
| 2016 |
Li HF, Hong Y, Zhang X, Xie Y, Skeie GO, Hao HJ, Gilhus NE, Liang B, Yue YX, Zhang XJ, Gao X, Wang Q, Gao Z, Ding XJ, Song M. Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis. Molecular Neurobiology. PMID 27501803 DOI: 10.1007/S12035-016-0024-Y |
0.359 |
|
| 2016 |
Gilhus NE, Kerty E, Løseth S, Mygland Å, Tallaksen C. [Myasthenia gravis - optimal treatment and accurate diagnosis]. Tidsskrift For Den Norske Laegeforening. 136: 1089-1094. PMID 27381787 DOI: 10.4045/Tidsskr.15.1259 |
0.369 |
|
| 2016 |
Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nature Reviews. Neurology. 12: 259-68. PMID 27103470 DOI: 10.1038/Nrneurol.2016.44 |
0.751 |
|
| 2016 |
Gotaas HT, Skeie GO, Gilhus NE. Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap. Neuromuscular Disorders. 26: 337-341. PMID 27102003 DOI: 10.1016/J.Nmd.2016.03.003 |
0.377 |
|
| 2016 |
Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, ... ... Gilhus NE, et al. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen. Journal of Neuroimmunology. 292: 108-15. PMID 26943968 DOI: 10.1016/J.Jneuroim.2016.01.018 |
0.531 |
|
| 2016 |
Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, ... ... Gilhus NE, et al. Titin antibodies in "seronegative" myasthenia gravis - A new role for an old antigen Journal of Neuroimmunology. 292: 108-115. DOI: 10.1016/j.jneuroim.2016.01.018 |
0.436 |
|
| 2015 |
Reiter SF, Veiby G, Bjørk MH, Engelsen BA, Daltveit AK, Gilhus NE. Psychiatric Comorbidity, Social Aspects and Quality of Life in a Population-Based Cohort of Expecting Fathers with Epilepsy. Plos One. 10: e0144159. PMID 26637130 DOI: 10.1371/Journal.Pone.0144159 |
0.551 |
|
| 2015 |
Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurology. 14: 1023-1036. PMID 26376969 DOI: 10.1016/S1474-4422(15)00145-3 |
0.439 |
|
| 2015 |
Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity. 48: 362-368. PMID 25915571 DOI: 10.3109/08916934.2015.1030614 |
0.402 |
|
| 2015 |
Bjørk MH, Veiby G, Reiter SC, Berle JØ, Daltveit AK, Spigset O, Engelsen BA, Gilhus NE. Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis. Epilepsia. 56: 28-39. PMID 25524160 DOI: 10.1111/Epi.12884 |
0.539 |
|
| 2015 |
Gilhus NE, Nacu A, Andersen JB, Owe JF. Myasthenia gravis and risks for comorbidity European Journal of Neurology. 22: 17-23. PMID 25354676 DOI: 10.1111/Ene.12599 |
0.426 |
|
| 2015 |
Hong Y, Li H, Skeie G, Gilhus N. Acetylcholine receptor and titin antibody in Chinese myasthenia gravis patients Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.089 |
0.45 |
|
| 2014 |
Heldal AT, Eide GE, Romi F, Owe JF, Gilhus NE. Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development. Plos One. 9: e114060. PMID 25464006 DOI: 10.1371/Journal.Pone.0114060 |
0.758 |
|
| 2014 |
Wolff AS, Kärner J, Owe JF, Oftedal BE, Gilhus NE, Erichsen MM, Kämpe O, Meager A, Peterson P, Kisand K, Willcox N, Husebye ES. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. Journal of Immunology (Baltimore, Md. : 1950). 193: 3880-90. PMID 25230752 DOI: 10.4049/Jimmunol.1401068 |
0.355 |
|
| 2014 |
Szczudlik P, Szyluk B, Lipowska M, Ryniewicz B, Kubiszewska J, Dutkiewicz M, Gilhus NE, Kostera-Pruszczyk A. Antititin antibody in early- and late-onset myasthenia gravis. Acta Neurologica Scandinavica. 130: 229-233. PMID 24947881 DOI: 10.1111/Ane.12271 |
0.524 |
|
| 2014 |
Andersen JB, Owe JF, Engeland A, Gilhus NE. Total drug treatment and comorbidity in myasthenia gravis: a population‐based cohort study European Journal of Neurology. 21: 948-955. PMID 24712740 DOI: 10.1111/Ene.12439 |
0.344 |
|
| 2014 |
Andersen JB, Heldal AT, Engeland A, Gilhus NE. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica. 129: 26-31. PMID 24588503 DOI: 10.1111/Ane.12233 |
0.384 |
|
| 2014 |
Stovner LJ, Hoff JM, Svalheim S, Gilhus NE. Neurological disorders in the Global Burden of Disease 2010 study Acta Neurologica Scandinavica. 129: 1-6. PMID 24588499 DOI: 10.1111/Ane.12229 |
0.674 |
|
| 2014 |
Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. Journal of Neurology. 261: 579-588. PMID 24449062 DOI: 10.1007/S00415-013-7239-X |
0.54 |
|
| 2013 |
Reiter SF, Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Psychiatric comorbidity and social aspects in pregnant women with epilepsy - the Norwegian Mother and Child Cohort Study. Epilepsy & Behavior : E&B. 29: 379-85. PMID 24074883 DOI: 10.1016/J.Yebeh.2013.08.016 |
0.55 |
|
| 2013 |
Veiby G, Daltveit AK, Schjølberg S, Stoltenberg C, Øyen AS, Vollset SE, Engelsen BA, Gilhus NE. Exposure to antiepileptic drugs in utero and child development: A prospective population-based study Epilepsia. 54: 1462-1472. PMID 23865818 DOI: 10.1111/Epi.12226 |
0.536 |
|
| 2013 |
Gjerstad L, Gilhus NE, Stovner LJ, Hoff JM. The Norwegian Brain Council ('Hjernerådet')--united efforts are necessary! Acta Neurologica Scandinavica. 127: 1-4. PMID 23190284 DOI: 10.1111/Ane.12042 |
0.662 |
|
| 2012 |
Maniaol A, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther HS, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud AK, Kerty E, Gilhus NE, Tallaksen C, et al. Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population Plos One. 7. PMID 22590574 DOI: 10.1371/Journal.Pone.0036603 |
0.388 |
|
| 2012 |
Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle & Nerve. 45: 815-9. PMID 22581533 DOI: 10.1002/Mus.23271 |
0.689 |
|
| 2012 |
Aarli JA, Gilhus NE, Lisak RP, Mantegazza R, Suzuki S. Myasthenia gravis. Autoimmune Diseases. 2011: 697575. PMID 22312479 DOI: 10.4061/2011/697575 |
0.739 |
|
| 2012 |
Romi F, Helgeland G, Gilhus NE. Serum levels of matrix metalloproteinases: implications in clinical neurology. European Neurology. 67: 121-8. PMID 22262194 DOI: 10.1159/000334862 |
0.65 |
|
| 2012 |
Romi F, Suzuki S, Suzuki N, Petzold A, Plant GT, Gilhus NE. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. Journal of Neurology. 259: 1312-6. PMID 22167224 DOI: 10.1007/S00415-011-6344-Y |
0.773 |
|
| 2012 |
Hapnes L, Willcox N, Oftedal BEV, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff ASB. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. Journal of Clinical Immunology. 32: 230-237. PMID 22127461 DOI: 10.1007/S10875-011-9617-4 |
0.387 |
|
| 2012 |
Gilhus NE. Advances in the treatment of myasthenia gravis Future Neurology. 7: 701-708. DOI: 10.2217/Fnl.12.73 |
0.393 |
|
| 2011 |
Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA. Myasthenia gravis: a review of available treatment approaches. Autoimmune Diseases. 2011: 847393. PMID 22007295 DOI: 10.4061/2011/847393 |
0.823 |
|
| 2011 |
Hoff JM, Loane M, Gilhus NE, Rasmussen S, Daltveit AK. Arthrogryposis multiplexa congenita: an epidemiologic study of nearly 9 million births in 24 EUROCAT registers. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 159: 347-50. PMID 22005589 DOI: 10.1016/J.Ejogrb.2011.09.027 |
0.743 |
|
| 2011 |
Gilhus NE. Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy. Autoimmune Diseases. 2011: 973808-973808. PMID 21969911 DOI: 10.4061/2011/973808 |
0.307 |
|
| 2011 |
Luckman SP, Gilhus NE, Romi F. Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls. Autoimmune Diseases. 2011: 151258. PMID 21826262 DOI: 10.4061/2011/151258 |
0.69 |
|
| 2011 |
Romi F, Helgeland G, Gilhus NE. Heat-shock proteins in clinical neurology. European Neurology. 66: 65-9. PMID 21757921 DOI: 10.1159/000329373 |
0.714 |
|
| 2011 |
Gilhus NE, Stovner LJ, Gjerstad L, Hoff JM. Partnership and cooperation is necessary to improve and expand neurology. Acta Neurologica Scandinavica. 124: 1-4. PMID 21711249 DOI: 10.1111/J.1600-0404.2011.01541.X |
0.689 |
|
| 2011 |
Borthen I, Eide MG, Daltveit AK, Gilhus NE. Obstetric outcome in women with epilepsy: A hospital-based, retrospective study Bjog: An International Journal of Obstetrics and Gynaecology. 118: 956-965. PMID 21557799 DOI: 10.1111/J.1471-0528.2011.03004.X |
0.547 |
|
| 2011 |
Gilhus NE. Neuromuscular disease: acute treatment for myasthenia gravis. Nature Reviews Neurology. 7: 132-134. PMID 21386868 DOI: 10.1038/Nrneurol.2011.14 |
0.324 |
|
| 2011 |
Alseth EH, Maniaol AH, Elsais A, Nakkestad HL, Tallaksen C, Gilhus NE, Skeie GO. Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. Muscle & Nerve. 43: 574-577. PMID 21305573 DOI: 10.1002/Mus.21919 |
0.359 |
|
| 2011 |
Power KN, Flaatten H, Gilhus NE, Engelsen BA. Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Research. 94: 53-60. PMID 21300522 DOI: 10.1016/J.Eplepsyres.2011.01.006 |
0.344 |
|
| 2011 |
Helgeland G, Petzold A, Luckman SP, Gilhus NE, Plant GT, Romi FR. Matrix metalloproteinases in myasthenia gravis. European Neurology. 65: 53-8. PMID 21212676 DOI: 10.1159/000322737 |
0.741 |
|
| 2010 |
Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, Grisold W, Honnorat J, Sillevis Smitt PA, Tanasescu R, Vedeler CA, Voltz R, Verschuuren JJ. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. European Journal of Neurology. 18: 19-e3. PMID 20880069 DOI: 10.1111/J.1468-1331.2010.03220.X |
0.492 |
|
| 2010 |
Borthen I, Eide MG, Daltveit AK, Gilhus NE. Delivery outcome of women with epilepsy: A population-based cohort study Bjog: An International Journal of Obstetrics and Gynaecology. 117: 1537-1543. PMID 20716254 DOI: 10.1111/J.1471-0528.2010.02694.X |
0.542 |
|
| 2010 |
Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR. Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome. Journal of Neuroimmunology. 225: 180-3. PMID 20554026 DOI: 10.1016/J.Jneuroim.2010.04.024 |
0.85 |
|
| 2010 |
Andersen JB, Engeland A, Owe JF, Gilhus NE. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 17: 1445-1450. PMID 20491896 DOI: 10.1111/J.1468-1331.2010.03089.X |
0.318 |
|
| 2010 |
Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 290: 66-9. PMID 20034637 DOI: 10.1016/J.Jns.2009.11.006 |
0.701 |
|
| 2010 |
Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, ... ... Gilhus NE, et al. Neurofilament ELISA validation. Journal of Immunological Methods. 352: 23-31. PMID 19857497 DOI: 10.1016/J.Jim.2009.09.014 |
0.494 |
|
| 2009 |
Borthen I, Eide MG, Veiby G, Daltveit AK, Gilhus NE. Complications during pregnancy in women with epilepsy: Population-based cohort study Bjog: An International Journal of Obstetrics and Gynaecology. 116: 1736-1742. PMID 19781049 DOI: 10.1111/J.1471-0528.2009.02354.X |
0.54 |
|
| 2009 |
Heldal AT, Owe JF, Gilhus NE, Romi F. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology. 73: 150-1. PMID 19597135 DOI: 10.1212/Wnl.0B013E3181Ad53C2 |
0.748 |
|
| 2009 |
Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 50: 2130-9. PMID 19490036 DOI: 10.1111/J.1528-1167.2009.02147.X |
0.538 |
|
| 2009 |
Alseth EH, Nakkestad HL, Aarseth J, Gilhus NE, Skeie GO. Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 210: 63-6. PMID 19299022 DOI: 10.1016/J.Jneuroim.2009.02.009 |
0.34 |
|
| 2009 |
Gilhus NE. Autoimmune myasthenia gravis Expert Review of Neurotherapeutics. 9: 351-358. PMID 19271944 DOI: 10.1586/14737175.9.3.351 |
0.492 |
|
| 2009 |
Gilhus NE. Is it safe to use statins in patients with myasthenia gravis Nature Reviews Neurology. 5: 8-9. PMID 19065133 DOI: 10.1038/Ncpneuro0988 |
0.458 |
|
| 2009 |
Aurlien H, Gjerde IO, Eide GE, Brøgger JC, Gilhus NE. Characteristics of generalised epileptiform activity. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 3-10. PMID 19059002 DOI: 10.1016/J.Clinph.2008.10.149 |
0.762 |
|
| 2009 |
Farbu E, Gilhus NE. Poliomyelitis: long-time consequences for social life. Acta Neurologica Scandinavica. 96: 353-358. PMID 9449471 DOI: 10.1111/J.1600-0404.1997.Tb00297.X |
0.302 |
|
| 2009 |
Gilhus NE, Aarli JA. Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients. Acta Neurologica Scandinavica. 63: 34-43. PMID 7468159 DOI: 10.1111/J.1600-0404.1981.Tb00746.X |
0.752 |
|
| 2009 |
Gilhus NE, Strandjord RE, Aarli JA. Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine Acta Neurologica Scandinavica. 62: 300-304. PMID 7468153 DOI: 10.1111/J.1600-0404.1980.Tb03040.X |
0.757 |
|
| 2009 |
Gilhus NE, Aarli JA. Effect of phenytoin on immunoglobulin concentrations in nasal secretions. Acta Pathologica Microbiologica Scandinavica Section C Immunology. 89: 63-68. PMID 7293776 DOI: 10.1111/J.1699-0463.1981.Tb02666.X |
0.748 |
|
| 2009 |
Vedeler CA, Gilhus NE, Matre R. Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravis Acta Neurologica Scandinavica. 82: 259-262. PMID 2148662 DOI: 10.1111/J.1600-0404.1990.Tb01616.X |
0.773 |
|
| 2009 |
Hofstad H, Ulvestad E, Gilhus NE, Matre R, Aarli JA. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups. Acta Neurologica Scandinavica. 85: 233-238. PMID 1585794 DOI: 10.1111/J.1600-0404.1992.Tb04037.X |
0.843 |
|
| 2009 |
Aarli JA, Gilhus NE, Romi F, Skeie GO. Myasthenia gravis in the elderly Aging Health. 5: 561-568. DOI: 10.2217/Ahe.09.44 |
0.763 |
|
| 2009 |
Hassel B, Gilhus NE, Aarli JA, Skogen OR. Fulminant myasthenia gravis and polymyositis after thymectomy for thymoma Acta Neurologica Scandinavica. 85: 63-65. DOI: 10.1111/j.1600-0404.1992.tb03997.x |
0.747 |
|
| 2009 |
Gilhus NE, Aarli JA, Janzen RWC, Otto HF, Matre R. Skeletal muscle antibodies in thymoma patients without myasthenia gravis Acta Neurologica Scandinavica. 69: 212-213. DOI: 10.1111/J.1600-0404.1984.Tb02443.X |
0.829 |
|
| 2009 |
Gilhus NE, Aarli JA, Christensson B, Matre R. Thymomas and skeletal muscle share an antigen in myasthenia gravis Acta Neurologica Scandinavica. 69: 210-211. DOI: 10.1111/J.1600-0404.1984.Tb02442.X |
0.799 |
|
| 2008 |
Owe JF, Davidsen ES, Eide GE, Gerdts E, Gilhus NE. Left ventricular long-axis function in myasthenia gravis Journal of Neurology. 255: 1777-1784. PMID 19156489 DOI: 10.1007/S00415-008-0049-X |
0.371 |
|
| 2008 |
Helgeland G, Luckman SP, Romi FR, Jonassen AK, Gilhus NE. Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology. 201: 74-9. PMID 18632164 DOI: 10.1016/J.Jneuroim.2008.05.021 |
0.705 |
|
| 2008 |
Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. Journal of Neurology. 255: 623-7. PMID 18283397 DOI: 10.1007/S00415-008-0757-2 |
0.531 |
|
| 2008 |
Romi FR, Gilhus NE, Luckman SP. Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 195: 96-9. PMID 18262287 DOI: 10.1016/J.Jneuroim.2007.10.018 |
0.69 |
|
| 2008 |
Aarli JA, Gilhus NE, Romi F, Skeie GO. Titin and ryanodine receptor antibodies and neuromuscular involvement in myasthenia gravis Future Neurology. 3: 87-92. DOI: 10.2217/14796708.3.1.87 |
0.855 |
|
| 2007 |
Amdahl C, Alseth EH, Gilhus NE, Nakkestad HL, Skeie GO. Polygenic disease associations in thymomatous myasthenia gravis. Archives of Neurology. 64: 1729-33. PMID 18071035 DOI: 10.1001/Archneur.64.12.1729 |
0.302 |
|
| 2007 |
Dahl J, Myhr K-, Daltveit AK, Skjaerven R, Gilhus NE. Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. European Journal of Neurology. 14: 1113-1117. PMID 17880567 DOI: 10.1111/J.1468-1331.2007.01913.X |
0.534 |
|
| 2007 |
Romi F, Aarli JA, Gilhus NE. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. European Journal of Neurology. 14: 617-620. PMID 17539937 DOI: 10.1111/J.1468-1331.2007.01785.X |
0.853 |
|
| 2007 |
Aurlien H, Aarseth JH, Gjerde IO, Karlsen B, Skeidsvoll H, Gilhus NE. Focal epileptiform activity described by a large computerised EEG database. Clinical Neurophysiology. 118: 1369-1376. PMID 17452009 DOI: 10.1016/J.Clinph.2007.02.027 |
0.686 |
|
| 2007 |
Veiby G, Daltveit AK, Gilhus NE. Pregnancy, delivery and perinatal outcome in female survivors of polio Journal of the Neurological Sciences. 258: 27-32. PMID 17395208 DOI: 10.1016/J.Jns.2007.02.019 |
0.536 |
|
| 2007 |
Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. European Journal of Neurology. 14: 60-65. PMID 17222115 DOI: 10.1111/J.1468-1331.2006.01552.X |
0.748 |
|
| 2007 |
Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. European Journal of Neurology. 14: 38-43. PMID 17222111 DOI: 10.1111/J.1468-1331.2006.01538.X |
0.77 |
|
| 2006 |
Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW. Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 17: 893-902. PMID 20402760 DOI: 10.1111/J.1468-1331.2010.03019.X |
0.341 |
|
| 2006 |
Dahl J, Myhr K-, Daltveit AK, Gilhus NE. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 113: 51-54. PMID 16637930 DOI: 10.1111/J.1600-0404.2006.00616.X |
0.533 |
|
| 2006 |
Owe JF, Daltveit AK, Gilhus NE. Does myasthenia gravis provide protection against cancer Acta Neurologica Scandinavica. 113: 33-36. PMID 16637926 DOI: 10.1111/J.1600-0404.2006.00612.X |
0.627 |
|
| 2006 |
Luckman SP, Skeie GO, Helgeland G, Gilhus NE. Effects of myasthenia gravis patient sera on human myoblast cultures. Acta Neurologica Scandinavica. 113: 28-32. PMID 16637925 DOI: 10.1111/J.1600-0404.2006.00611.X |
0.425 |
|
| 2006 |
Hoff JM, Daltveit AK, Gilhus NE. Artrogryposis multiplex congenita -- a rare fetal condition caused by maternal myasthenia gravis. Acta Neurologica Scandinavica. 113: 26-27. PMID 16637924 DOI: 10.1111/J.1600-0404.2006.00610.X |
0.778 |
|
| 2006 |
Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: disease severity and prognosis. Acta Neurologica Scandinavica. 113: 24-25. PMID 16637923 DOI: 10.1111/J.1600-0404.2006.00609.X |
0.823 |
|
| 2006 |
Skeie GO, Aarli JA, Gilhus NE. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurologica Scandinavica. 113: 19-23. PMID 16637922 DOI: 10.1111/J.1600-0404.2006.00608.X |
0.814 |
|
| 2006 |
Owe JF, Daltveit AK, Gilhus NE. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001 Journal of Neurology, Neurosurgery, and Psychiatry. 77: 203-207. PMID 16421123 DOI: 10.1136/Jnnp.2005.072355 |
0.616 |
|
| 2006 |
Luckman SP, Skeie GO, Helgeland G, Gilhus NE. Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle & Nerve. 33: 93-103. PMID 16228972 DOI: 10.1002/Mus.20443 |
0.426 |
|
| 2006 |
Gilhus NE, Tysnes O, Vedeler CA. Introduction Acta Neurologica Scandinavica. 113: v-vi. DOI: 10.1111/j.1600-0404.2006.00604.x |
0.402 |
|
| 2005 |
Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 65: 1961-1963. PMID 16380620 DOI: 10.1212/01.Wnl.0000188898.02018.95 |
0.741 |
|
| 2005 |
Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. European Journal of Neurology. 12: 413-418. PMID 15885043 DOI: 10.1111/J.1468-1331.2005.01137.X |
0.852 |
|
| 2005 |
Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Archives of Neurology. 62: 442-6. PMID 15767509 DOI: 10.1001/Archneur.62.3.442 |
0.84 |
|
| 2005 |
Hoff JM, Gilhus NE, Daltveit AK. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 64: 459-462. PMID 15699375 DOI: 10.1212/01.Wnl.0000150933.65709.96 |
0.75 |
|
| 2005 |
Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurologica Scandinavica. 111: 134-141. PMID 15644074 DOI: 10.1111/J.1600-0404.2005.00374.X |
0.766 |
|
| 2005 |
Romi F, Kristoffersen EK, Aarli JA, Gilhus NE. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 158: 191-4. PMID 15589053 DOI: 10.1016/J.Jneuroim.2004.08.002 |
0.814 |
|
| 2004 |
Hoff JM, Daltveit AK, Gilhus NE. Asymptomatic myasthenia gravis influences pregnancy and birth. European Journal of Neurology. 11: 559-562. PMID 15272902 DOI: 10.1111/J.1468-1331.2004.00900.X |
0.778 |
|
| 2004 |
Aurlien H, Gjerde IO, Aarseth JH, Eldøen G, Karlsen B, Skeidsvoll H, Gilhus NE. EEG background activity described by a large computerized database. Clinical Neurophysiology. 115: 665-673. PMID 15036063 DOI: 10.1016/J.Clinph.2003.10.019 |
0.678 |
|
| 2004 |
Romi F, Gilhus NE, Aarli JA. [Thymectomy and muscle antibodies in myasthenia gravis]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 124: 629-31. PMID 15004605 |
0.748 |
|
| 2004 |
Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA. Lifestyle and late effects after poliomyelitis. A risk factor study of two populations. Acta Neurologica Scandinavica. 109: 120-125. PMID 14705974 DOI: 10.1034/J.1600-0404.2003.00186.X |
0.735 |
|
| 2003 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study European Journal of Neurology. 10: 701-706. PMID 14641516 DOI: 10.1046/J.1468-1331.2003.00678.X |
0.836 |
|
| 2003 |
Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis: Consequences for pregnancy, delivery, and the newborn Neurology. 61: 1362-1366. PMID 14638956 DOI: 10.1212/01.Wnl.0000082725.21444.Ec |
0.772 |
|
| 2003 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 998: 481-90. PMID 14592917 DOI: 10.1196/Annals.1254.062 |
0.842 |
|
| 2003 |
Agius MA, Richman DP, Fairclough RH, Aarli J, Gilhus NE, Romi F. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6. PMID 14592914 DOI: 10.1196/Annals.1254.059 |
0.825 |
|
| 2003 |
Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia Gravis in Individuals over 40 Annals of the New York Academy of Sciences. 998: 424-431. PMID 14592910 DOI: 10.1196/Annals.1254.055 |
0.786 |
|
| 2003 |
Skeie GO, Romi F, Aarli JA, Bentsen PT, Gilhus NE. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 998: 343-50. PMID 14592894 DOI: 10.1196/Annals.1254.039 |
0.851 |
|
| 2003 |
Farbu E, Rekand T, Gilhus NE. Post-polio syndrome and total health status in a prospective hospital study European Journal of Neurology. 10: 407-413. PMID 12823493 DOI: 10.1046/J.1468-1331.2003.00613.X |
0.32 |
|
| 2003 |
Farbu E, Rekand T, Tysnes O-, Aarli JA, Gilhus NE, Vedeler CA. GM1 antibodies in post-polio syndrome and previous paralytic polio. Journal of Neuroimmunology. 139: 141-144. PMID 12799031 DOI: 10.1016/S0165-5728(03)00123-1 |
0.818 |
|
| 2003 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European Neurology. 49: 210-217. PMID 12736536 DOI: 10.1159/000070185 |
0.85 |
|
| 2003 |
Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA. Long term outcome after poliomyelitis in different health and social conditions Journal of Epidemiology and Community Health. 57: 368-372. PMID 12700222 DOI: 10.1136/Jech.57.5.368 |
0.733 |
|
| 2003 |
Skeie GO, Mygland A, Treves S, Gilhus NE, Aarli JA, Zorzato F. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle & Nerve. 27: 81-9. PMID 12508299 DOI: 10.1002/Mus.10294 |
0.778 |
|
| 2002 |
Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. Journal of Neuroimmunology. 128: 82-9. PMID 12098514 DOI: 10.1016/S0165-5728(02)00145-5 |
0.846 |
|
| 2002 |
Farbu E, Gilhus NE. Education, occupation, and perception of health amongst previous polio patients compared to their siblings. European Journal of Neurology. 9: 233-241. PMID 11985631 DOI: 10.1046/J.1468-1331.2002.00390.X |
0.337 |
|
| 2002 |
Farbu E, Gilhus NE. Former poliomyelitis as a health and socioeconomic factor. A paired sibling study. Journal of Neurology. 249: 404-409. PMID 11967644 DOI: 10.1007/S004150200030 |
0.315 |
|
| 2002 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. European Journal of Neurology. 9: 55-61. PMID 11784377 DOI: 10.1046/J.1468-1331.2002.00352.X |
0.857 |
|
| 2001 |
Farbu E, Rekand T, Aarli JA, Gilhus NE. Polio survivors--well educated and hard working. Journal of Neurology. 248: 500-505. PMID 11499641 DOI: 10.1007/S004150170160 |
0.739 |
|
| 2001 |
Skeie GO, Lunde PK, Sejersted OM, Mygland Å, Aarli JA, Gilhus NE. Autoimmunity against the ryanodine receptor in myasthenia gravis. Acta Physiologica Scandinavica. 171: 379-384. PMID 11412151 DOI: 10.1046/J.1365-201X.2001.00841.X |
0.809 |
|
| 2000 |
Willison H, Ang W, Gilhus NE, Graus F, Liblau R, Vedeler C, Vincent A. EFNS Task Force Report: a questionnaire‐based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres European Journal of Neurology. 7: 625-628. PMID 11136347 DOI: 10.1046/J.1468-1331.2000.00158.X |
0.563 |
|
| 2000 |
Romi F, Skeie GO, Aarli JA, Gilhus NE. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Jama Neurology. 57: 1596-1600. PMID 11074791 DOI: 10.1001/Archneur.57.11.1596 |
0.855 |
|
| 2000 |
Romi F, Skeie GO, Vedeler C, Aarli JA, Zorzato F, Gilhus NE. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations. Journal of Neuroimmunology. 111: 169-76. PMID 11063835 DOI: 10.1016/S0165-5728(00)00394-5 |
0.845 |
|
| 2000 |
Romi F, Skeie GO, Aarli JA, Gilhus NE. Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 247: 369-375. PMID 10896269 DOI: 10.1007/S004150050604 |
0.846 |
|
| 2000 |
Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, Gilhus NE, Aarli JA. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Archives of Neurology. 57: 527-31. PMID 10768628 DOI: 10.1001/Archneur.57.4.527 |
0.818 |
|
| 1999 |
Aurlien H, Gjerde IO, Gilhus NE, Hovstad OG, Karlsen B, Skeidsvoll H. A new way of building a database of EEG findings. Clinical Neurophysiology. 110: 986-995. PMID 10400215 DOI: 10.1016/S1388-2457(99)00037-1 |
0.675 |
|
| 1999 |
Skeie GO, Pandey JP, Aarli JA, Gilhus NE. TNFA and TNFB polymorphisms in myasthenia gravis. Archives of Neurology. 56: 457-61. PMID 10199335 DOI: 10.1001/Archneur.56.4.457 |
0.707 |
|
| 1998 |
Skeie GO, Lunde PK, Sejersted OM, Mygland Å, Aarli JA, Gilhus NE. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. Annals of the New York Academy of Sciences. 841: 530-533. PMID 9668288 DOI: 10.1111/J.1749-6632.1998.Tb10976.X |
0.76 |
|
| 1998 |
Aarli JA, Skeie GO, Mygland Å, Gilhus NE. Muscle Striation Antibodies in Myasthenia Gravis: Diagnostic and Functional Significance Annals of the New York Academy of Sciences. 841: 505-515. PMID 9668283 DOI: 10.1111/J.1749-6632.1998.Tb10971.X |
0.778 |
|
| 1998 |
Skeie G, Freiburg A, Kolmerer B, Labeit S, Aarli JA, Gilhus NE. Titin Transcripts in Thymomas Annals of the New York Academy of Sciences. 841: 422-426. PMID 9668270 DOI: 10.1111/J.1749-6632.1998.Tb10958.X |
0.683 |
|
| 1998 |
Raknes G, Skeie GO, Gilhus NE, Aadland S, Vedeler C. FcγRIIA and FcγRIIIB polymorphisms in myasthenia gravis Journal of Neuroimmunology. 81: 173-176. PMID 9521619 DOI: 10.1016/S0165-5728(97)00174-4 |
0.629 |
|
| 1998 |
Lübke E, Freiburg A, Skeie GO, Kolmerer B, Labeit S, Aarli JA, Gilhus NE, Wollmann R, Wussling M, Rüegg JC, Linke WA. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. Journal of Neuroimmunology. 81: 98-108. PMID 9521611 DOI: 10.1016/S0165-5728(97)00164-1 |
0.789 |
|
| 1998 |
Skeie GO, Lunde PK, Sejersted OM, Mygland Å, Aarli JA, Gilhus NE. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]‐ryanodine to sacroplasmic reticulum Muscle & Nerve. 21: 329-335. PMID 9486861 DOI: 10.1002/(Sici)1097-4598(199803)21:3<329::Aid-Mus6>3.0.Co;2-C |
0.801 |
|
| 1998 |
Skeie GO, Bentsen PT, Freiburg A, Aarli JA, Gilhus NE. Cell-Mediated Immune Response Against Titin In Myasthenia Gravis : Evidence For The Involvement Of Th1 And Th2 Cells Scandinavian Journal of Immunology. 47: 76-81. PMID 9467662 DOI: 10.1046/J.1365-3083.1998.00260.X |
0.793 |
|
| 1998 |
Myking AO, Skeie GO, Varhaug JE, Andersen KS, Gilhus NE, Aarli JA. The histomorphology of the thymus in late onset, non‐thymoma myasthenia gravis European Journal of Neurology. 5: 401-405. DOI: 10.1046/J.1468-1331.1998.540401.X |
0.794 |
|
| 1997 |
Skeie GO, Aarli JA, Matre R, Freiburg A, Gilhus NE. Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. European Journal of Neurology. 4: 131-137. PMID 24283905 DOI: 10.1111/J.1468-1331.1997.Tb00318.X |
0.828 |
|
| 1997 |
Skeie GO, Pandey JP, Aarli JA, Gilhus NE. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 26: 111-6. PMID 9546812 DOI: 10.3109/08916939709003854 |
0.791 |
|
| 1997 |
Skeie GO, Freiburg A, Kolmerer B, Labeit S, Aarli JA, Appiah-Boadu S, Gilhus NE. Titin transcripts in thymomas. Journal of Autoimmunity. 10: 551-557. PMID 9451594 DOI: 10.1006/Jaut.1997.0162 |
0.785 |
|
| 1997 |
Skeie GO, Bentsen PT, Aarli JA, Gilhus NE. 4-34-10 Cell mediated immune response against titin in myasthenia gravis; evidence for the involvement of TH1 cells Journal of the Neurological Sciences. 150. DOI: 10.1016/S0022-510X(97)86128-X |
0.706 |
|
| 1996 |
Mygland A, Kuwajima G, Mikoshiba K, Tysnes OB, Aarli JA, Gilhus NE. Thymomas express epitopes shared by the ryanodine receptor. Journal of Neuroimmunology. 62: 79-83. PMID 7499495 DOI: 10.1016/0165-5728(95)00106-C |
0.786 |
|
| 1996 |
Skeie GO, Bartoccioni E, Evoli A, Aarli JA, Gilhus NE. Ryanodine receptor antibodies are associated with severe myasthenia gravis European Journal of Neurology. 3: 136-140. DOI: 10.1111/J.1468-1331.1996.Tb00205.X |
0.823 |
|
| 1995 |
Skeie GO, Mygland Á, Aarli JA, Gilhus NE. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity. 20: 99-104. PMID 7578874 DOI: 10.3109/08916939509001933 |
0.819 |
|
| 1994 |
Mygland A, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 843-846. PMID 8021674 DOI: 10.1136/Jnnp.57.7.843 |
0.841 |
|
| 1994 |
Salonen R, Ashford E, Dahlöf C, Dawson R, Gilhus NE, Lüben V, Noronha D, Warter JM. Intranasal sumatriptan for the acute treatment of migraine Journal of Neurology. 241: 463-469. PMID 7964913 DOI: 10.1007/Bf00919706 |
0.34 |
|
| 1994 |
Mygland A, Tysnes OB, Matre R, Aarli JA, Gilhus NE. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis. Autoimmunity. 17: 327-31. PMID 7948615 DOI: 10.3109/08916939409010673 |
0.835 |
|
| 1994 |
Bates D, Ashford E, Dawson R, Ensink FM, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P. Subcutaneous sumatriptan during the migraine aura Neurology. 44: 1587-1587. PMID 7936279 DOI: 10.1212/Wnl.44.9.1587 |
0.328 |
|
| 1994 |
Mygland Å, Aarli JA, Gilhus NE. Anti-ryanodine receptor antibodies in thymoma-associated myasthenia gravis Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90177-5 |
0.776 |
|
| 1994 |
Aarli J, Stefansson K, Gautel M, Labeit S, Mygland Å, Gilhus N. Titin is a major autoantigen in MG Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90171-6 |
0.753 |
|
| 1994 |
Gilhus NE, Jones M, Nagvekar N, Turley H, Newsom-Davis J, Willcox N. Oncogene markers in thymomas from myasthenia gravis patients Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90159-7 |
0.337 |
|
| 1994 |
Mygland Å, Aarli JA, Gilhus NE. Severity of thymoma-associated myasthenia gravis is related to the presence of anti-ryanodine receptor antibodies Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90135-X |
0.775 |
|
| 1994 |
Gilhus NE, Nagvekar N, Willcox N, Harcourt G, Beeson D, Vincent A, Newsom-Davis J. Myasthenia gravis: Antigen presentation by thymoma epithelial cells Journal of Neuroimmunology. 54: 163. DOI: 10.1016/0165-5728(94)90328-X |
0.317 |
|
| 1993 |
Gautel M, Lakey A, Barlow DP, Holmes Z, Scales S, Leonard K, Labeit S, Mygland A, Gilhus NE, Aarli JA. Titin antibodies in myasthenia gravis Identification of a major immunogenic region of titin Neurology. 43: 1581-1581. PMID 8351016 DOI: 10.1212/Wnl.43.8.1581 |
0.786 |
|
| 1993 |
Mygland A, Tysnes OB, Aarli JA, Matre R, Gilhus NE. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. Journal of Autoimmunity. 6: 507-15. PMID 8216692 DOI: 10.1006/Jaut.1993.1042 |
0.842 |
|
| 1992 |
Johannessen KA, Mygland A, Gilhus NE, Aarli J, Vik-Mo H. Left ventricular function in myasthenia gravis. The American Journal of Cardiology. 69: 129-32. PMID 1729861 DOI: 10.1016/0002-9149(92)90688-U |
0.719 |
|
| 1992 |
Aarli JA, Gilhus NE, Matre R. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders. Autoimmunity. 11: 159-162. PMID 1571478 DOI: 10.3109/08916939209035150 |
0.83 |
|
| 1992 |
Hofstad H, Gilhus NE, Matre R, Aarli JA. Non-receptor muscle antibodies in myasthenia gravis are of IgG1 and IgG4 subclasses. Autoimmunity. 12: 271-276. PMID 1391596 DOI: 10.3109/08916939209148469 |
0.843 |
|
| 1992 |
Mygland A, Tysnes OB, Aarli JA, Flood PR, Gilhus NE. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. Journal of Neuroimmunology. 37: 1-7. PMID 1372324 DOI: 10.1016/0165-5728(92)90150-J |
0.811 |
|
| 1992 |
Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Annals of Neurology. 32: 589-91. PMID 1333745 DOI: 10.1002/ANA.410320419 |
0.824 |
|
| 1991 |
Gilhus NE, Hammarström L. Anti-IgA antibodies in epileptic patients with a low serum IgA concentration. International Journal of Immunopharmacology. 13: 185-188. PMID 2071295 DOI: 10.1016/0192-0561(91)90097-Q |
0.458 |
|
| 1991 |
Spurkland A, Gilhus NE, Rønningen KS, Aarli JA, Vartdal F. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations Tissue Antigens. 37: 90-93. PMID 2057938 DOI: 10.1111/J.1399-0039.1991.Tb01851.X |
0.753 |
|
| 1991 |
Mygland Å, Aarli JA, Hofstad H, Gilhus NE. Heart muscle antibodies in myasthenia gravis. Autoimmunity. 10: 263-267. PMID 1772962 DOI: 10.3109/08916939109001899 |
0.804 |
|
| 1991 |
Mygland Å, Tysnes O, Aarli J, Flood P, Gilhus N. Myasthenia gravis patients with a thymoma have antibodies against a sarcoplasmic reticulum protein Journal of Autoimmunity. 4: xlii. DOI: 10.1016/0896-8411(91)90139-4 |
0.787 |
|
| 1991 |
Mygland A, Johannessen KA, Aarli JA, Gilhus NE. Reduced diastolic heart function in patients with myasthenia gravis Journal of Autoimmunity. 4. DOI: 10.1016/0896-8411(91)90087-S |
0.721 |
|
| 1991 |
Aarli JA, Gilhus NE, Matre R. Autoimmunity and thymus pathology in myasthenia gravis Journal of Neuroimmunology. 35: 102. DOI: 10.1016/0165-5728(91)91027-A |
0.786 |
|
| 1991 |
Hofstad H, Ulvestad E, Gilhus NE, Matre R, Aarli JA. Ig classes and IgG subclasses of non-receptor muscle antibodies in myasthenia gravis: Relationship to thymus pathology Journal of Neuroimmunology. 35: 69. DOI: 10.1016/0165-5728(91)90963-8 |
0.823 |
|
| 1990 |
Gilhus NE, Pandey JP, Gaarder PI, Aarli JA. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. Journal of Autoimmunity. 3: 299-305. PMID 2397020 DOI: 10.1016/0896-8411(90)90148-L |
0.781 |
|
| 1990 |
Vedeler CA, Gilhus NE, Matre R. Erythrocyte C3b/C4b receptors (CR1) in patients with myasthenia gravis. Autoimmunity. 6: 235-236. PMID 2151792 DOI: 10.3109/08916939009041043 |
0.745 |
|
| 1989 |
Aarli JA, Gilhus NE, Thorlacius S, Johnsen HJ. Recovery from global amnesia during plasma exchange in myasthenia gravis: report of a case. Acta Neurologica Scandinavica. 80: 351-353. PMID 2816294 DOI: 10.1111/J.1600-0404.1989.Tb03892.X |
0.702 |
|
| 1989 |
Gilhus NE, Lea T. IgG subclasses in epileptic patients treated with phenytoin. Journal of Neurology. 236: 149-152. PMID 2496207 DOI: 10.1007/Bf00314330 |
0.452 |
|
| 1989 |
Aarli JA, Aarli JA, Thorlacius S, Gilhus NE, Hofstad H. Abstract of the Second European Conference on Myasthenia Gravis held in Tremezzo, Italy on 12–14 June 1989CNS involvement in myasthenia gravis Journal of Autoimmunity. 2: 934-935. DOI: 10.1016/0896-8411(89)90075-9 |
0.714 |
|
| 1989 |
Hofstad H, Aarli J, Gilhus N, Hofstad H, Flood P, Tysnes O. Antibodies against sarcoplasmic reticulum in serum from patients with myasthenia gravis Journal of Autoimmunity. 2: 925-926. DOI: 10.1016/0896-8411(89)90060-7 |
0.797 |
|
| 1989 |
Gilhus NE, Gilhus N, Pandey J, Gaarder P, Aarli J. Immunoglobulin allotypes in myasthenia gravis (MG) patients with thymoma and non-receptor antibodies Journal of Autoimmunity. 2: 897. DOI: 10.1016/0896-8411(89)90017-6 |
0.81 |
|
| 1988 |
Gilhus NE, Lea T. Carbamazepine: Effect on IgG Subclasses in Epileptic Patients Epilepsia. 29: 317-320. PMID 3371285 DOI: 10.1111/J.1528-1157.1988.Tb03726.X |
0.326 |
|
| 1987 |
Aarli JA, Gilhus NE, Hofstad H. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis? Acta Neurologica Scandinavica. 76: 55-57. PMID 3630645 DOI: 10.1111/J.1600-0404.1987.Tb03544.X |
0.793 |
|
| 1987 |
Thorlacius S, Aarli JA, Gilhus NE, Hofstad H. Muscle antibodies in the cerebrospinal fluid from patients with myasthenia gravis. Acta Neurologica Scandinavica. 75: 423-426. PMID 3630637 DOI: 10.1111/J.1600-0404.1987.Tb05472.X |
0.79 |
|
| 1987 |
Iivanainen M, Syrjänen J, Waltimo O, Valtonen VV, Gilhus NE. Increased bacterial antibody titres and IgA deficiency in epileptic patients. British Medical Journal (Clinical Research Ed.). 294: 677. PMID 3105682 DOI: 10.1136/BMJ.294.6573.677 |
0.338 |
|
| 1987 |
Flood PR, Bjugn R, Gilhus NE, Hofstad H, Matre R, Aarli JA. The Ultrastructural Localization of Antigens for Skeletal Muscle Antibodies in Myasthenia Gravis Annals of the New York Academy of Sciences. 505: 732-734. DOI: 10.1111/J.1749-6632.1987.Tb51353.X |
0.82 |
|
| 1987 |
Gilhus NE, Hofstad H, Matre R, Aarli JA. Fcγ receptors on thymomas from patients with myasthenia gravis (MG) Journal of Neuroimmunology. 16: 62-63. DOI: 10.1016/0165-5728(87)90224-4 |
0.813 |
|
| 1986 |
Thorlacius S, Lefvert AK, Aarli JA, Gilhus NE, Halvorsen K, Hofstad H, Matre R, Tönder O. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies. Acta Neurologica Scandinavica. 74: 486-90. PMID 3825504 DOI: 10.1111/J.1600-0404.1986.Tb07875.X |
0.833 |
|
| 1986 |
Gilhus NE, Matre R. Carbamazepine effects on mononuclear blood cells in epileptic patients. Acta Neurologica Scandinavica. 74: 181-185. PMID 3491486 DOI: 10.1111/J.1600-0404.1986.Tb07852.X |
0.679 |
|
| 1986 |
Gilhus NE, Matre R. Fcγ receptors and HLA-DR antigens on thymus cells in myasthenia gravis Journal of Neuroimmunology. 10: 271-278. PMID 2934405 DOI: 10.1016/0165-5728(86)90107-4 |
0.732 |
|
| 1986 |
Gilhus NE, Matre R, Aarli JA, Hofstad H, Thunold S. Thymic lymphoepitheliomas and skeletal muscle expressing common antigen(s). Acta Neurologica Scandinavica. 73: 428-433. PMID 2425540 DOI: 10.1111/J.1600-0404.1986.Tb03300.X |
0.839 |
|
| 1985 |
Gilhus NE, Aarli JA, Janzen RWC, Otto HF, Fasske E, Matre R. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis Journal of Neuroimmunology. 8: 69-78. PMID 3998123 DOI: 10.1016/S0165-5728(85)80048-5 |
0.844 |
|
| 1984 |
Gilhus NE, Aarli JA, Christensson B, Matre R. Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients. Journal of Neuroimmunology. 7: 55-64. PMID 6389592 DOI: 10.1016/S0165-5728(84)80006-5 |
0.8 |
|
| 1984 |
Gilhus NE, Aarli JA, Matre R. Myasthenia gravis Difference between thymoma‐associated antibodies and crossstriational skeleta1 muscle antibodies Neurology. 34: 246-246. PMID 6363971 DOI: 10.1212/Wnl.34.2.246 |
0.844 |
|
| 1983 |
Gilhus NE. The in vitro effect of phenytoin and carbamazepine on subpopulations of human blood mononuclear cells. International Journal of Immunopharmacology. 5: 283-288. PMID 6605315 DOI: 10.1016/0192-0561(83)90030-9 |
0.319 |
|
| 1983 |
Gilhus NE, Aarli JA, Matre R. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies. Acta Neurologica Scandinavica. 68: 328-336. PMID 6364682 DOI: 10.1111/J.1600-0404.1983.Tb04840.X |
0.841 |
|
| 1983 |
Gilhus NE, Aarli JA, Matre R. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens. Journal of Neuroimmunology. 5: 239-249. PMID 6361067 DOI: 10.1016/0165-5728(83)90044-9 |
0.827 |
|
| 1983 |
Gilhus NE, Matre R. The ontogeny of T-cell antigens in the thymus. Scandinavian Journal of Immunology. 17: 323-328. PMID 6340182 DOI: 10.1111/J.1365-3083.1983.Tb00796.X |
0.668 |
|
| 1982 |
Gilhus NE, Aarli JA, Thorsby E. HLA antigens in epileptic patients with drug-induced immunodeficiency International Journal of Immunopharmacology. 4: 517-520. PMID 7152760 DOI: 10.1016/0192-0561(82)90031-5 |
0.762 |
|
| 1982 |
Gilhus NE, Strandjord RE, Aarli JA. The effect of carbamazepine on serum immunoglobulin concentrations Acta Neurologica Scandinavica. 66: 172-179. PMID 7136483 DOI: 10.1111/J.1600-0404.1982.Tb04514.X |
0.746 |
|
| 1982 |
Gilhus NE, Strandjord RE, Aarli JA. Respiratory Disease in Patients with Epilepsy on Single-Drug Therapy with Carbamazepine or Phenobarbital European Neurology. 21: 284-288. PMID 7117316 DOI: 10.1159/000115493 |
0.742 |
|
| 1982 |
Gilhus NE, Matre R. In vitro Effect of Ethanol on Subpopulations of Human Blood Mononuclear Cells International Archives of Allergy and Immunology. 68: 382-386. PMID 6980194 DOI: 10.1159/000233130 |
0.64 |
|
| 1982 |
Gilhus NE, Matre R, Aarli JA. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. International Journal of Immunopharmacology. 4: 43-48. PMID 6979523 DOI: 10.1016/0192-0561(82)90007-8 |
0.797 |
|
| 1982 |
Gilhus NE, Frostad S, Matre R, Tönder O. The ontogeny of immunological receptors in the thymus. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology. 90: 307-14. PMID 6221505 DOI: 10.1111/J.1699-0463.1982.Tb01455.X |
0.66 |
|
| 1982 |
Gilhus NE, Matre R, Aarli JA. Alpha-fetoprotein concentrations in sera from epileptic patients with immunodeficiency. International Journal of Immunopharmacology. 4: 423-427. PMID 6182118 DOI: 10.1016/0192-0561(82)90016-9 |
0.799 |
|
| 1982 |
Bergstrand H, Frick I, Lindhqvist V, Lundqvist B, Nyström I, Schurmann A, Edwards RG, Spackman DA, Dewdney JM, Bjerke JR, Krogh H, Matre R, Radermecker M, Maldague MP, Gustin M, ... ... Gilhus NE, et al. Contents, Vol. 68, 1982 International Archives of Allergy and Immunology. 68. DOI: 10.1159/000233115 |
0.633 |
|
| 1981 |
Gilhus NE, Aarli JA. The reversibility of phenytoin-induced IgA deficiency. Journal of Neurology. 226: 53-61. PMID 6181216 DOI: 10.1007/Bf00313318 |
0.752 |
|
| 1980 |
Naess A, Gilhus NE, Aarli JA. Lymphocyte subpopulations and IgG concentrations in cerebrospinal fluid and blood from patients with myasthenia gravis. Scandinavian Journal of Immunology. 11: 431-6. PMID 6966819 DOI: 10.1111/j.1365-3083.1980.tb00009.x |
0.762 |
|
| Show low-probability matches. |